100 related articles for article (PubMed ID: 3481847)
1. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].
Marni E; Marchi A; Laini C; Zanol MG; Martini A; Livieri C; Genova R
Minerva Pediatr; 1978 Feb; 30(4):333-8. PubMed ID: 273716
[No Abstract] [Full Text] [Related]
3. Early onset of daunomycin cardiotoxicity in a case of acute myelogeneous leukemia associated with Sweet's syndrome.
Imamura N; Miura K; Kuramoto A
Hiroshima J Med Sci; 1985 Jun; 34(2):253-6. PubMed ID: 3861598
[No Abstract] [Full Text] [Related]
4. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.
Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389
[No Abstract] [Full Text] [Related]
5. [Sudden death in leukemic patients treated with doxorubicin].
Lacasse Y; Bolduc P
Can J Cardiol; 1992; 8(1):53-6. PubMed ID: 1617512
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy.
Lemez P; Maresová J
Semin Oncol; 1998 Aug; 25(4 Suppl 10):61-5. PubMed ID: 9768826
[TBL] [Abstract][Full Text] [Related]
7. Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study.
Fassas A; Buffels R; Anagnostopoulos A; Gacos E; Vadikolia C; Haloudis P; Kaloyannidis P
Br J Haematol; 2002 Feb; 116(2):308-15. PubMed ID: 11841431
[TBL] [Abstract][Full Text] [Related]
8. [Cardiotoxicity in long term treatment with cytostatics (author's transl)].
Fuhrmann U; Rieger M; Franz Ch
Dtsch Med Wochenschr; 1978 Mar; 103(9):387-90. PubMed ID: 272983
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
[TBL] [Abstract][Full Text] [Related]
10. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for development of daunorubicin cardiotoxicity.
Von Hoff DD; Layard M
Cancer Treat Rep; 1981; 65 Suppl 4():19-23. PubMed ID: 7049377
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia.
Goemans BF; Zwaan CM; Reinhardt D; Gibson BE; Hählen K; Kaspers GJ
Haematologica; 2006 Nov; 91(11):1573-4. PubMed ID: 17043024
[TBL] [Abstract][Full Text] [Related]
13. Time relationship between last dose of daunorubicin and congestive heart failure.
Von Hoff DD; Layard M; Rozencweig M; Muggia FM
Cancer Treat Rep; 1977 Oct; 61(7):1411-3. PubMed ID: 271046
[No Abstract] [Full Text] [Related]
14. Heart transplant in a childhood leukemia survivor: a case report.
Urbanova D; Bubanska E; Hrebik M; Mladosievicova B
Exp Clin Transplant; 2010 Mar; 8(1):79-81. PubMed ID: 20199376
[TBL] [Abstract][Full Text] [Related]
15. [Cardiotoxic effect of anthracycline antibiotics].
Jovanović I; Ceranić LJ; Simeunović S; Cvetković P
Bilt Hematol Transfuz; 1983; 11(2-3):51-7. PubMed ID: 6680300
[TBL] [Abstract][Full Text] [Related]
16. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
[TBL] [Abstract][Full Text] [Related]
17. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
Bauters F; Plouvier B; Breviere G; Goudemand M
Sem Hop; 1975 Jun; 51(28):1949-57. PubMed ID: 180611
[TBL] [Abstract][Full Text] [Related]
19. Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.
Thomas X; Le QH; Fiere D
Ann Hematol; 2002 Sep; 81(9):504-7. PubMed ID: 12373350
[TBL] [Abstract][Full Text] [Related]
20. [Daunomycin and atrial fibrillation].
Fuster Siebert M; Fernández Iglesias A; Couselo Sánchez JM; Gallego García D; Iglesias Diz JL; Alvez González F
An Esp Pediatr; 1983 Nov; 19(5):415-6. PubMed ID: 6581751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
